Primary hyperoxaluria diagnosed after kidney transplantation failure: lesson from 3 case reports and literature review

[1]  Jinyu Yu,et al.  Recurrent primary hyperoxaluria type 2 leads to early post-transplant renal function loss: A case report , 2018, Experimental and therapeutic medicine.

[2]  A. Flórez,et al.  Primary hiperoxaluria diagnosed after kidney transplantation: report of 2 cases and literature review. , 2017, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

[3]  E. Salido,et al.  Molecular therapy of primary hyperoxaluria , 2017, Journal of Inherited Metabolic Disease.

[4]  M. Vicent,et al.  Use of polymer conjugates for the intraperoxisomal delivery of engineered human alanine:glyoxylate aminotransferase as a protein therapy for primary hyperoxaluria type I. , 2017, Nanomedicine : nanotechnology, biology, and medicine.

[5]  E. Salido,et al.  Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  E. Salido,et al.  Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1 , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  N. Brunetti‐Pierri,et al.  Helper-dependent adenoviral vectors for liver-directed gene therapy of primary hyperoxaluria type 1 , 2015, Gene Therapy.

[8]  P. Clayton,et al.  Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I. , 2015, Human molecular genetics.

[9]  M. Ganji,et al.  Primary hyperoxaluria type 1 diagnosed after kidney transplantation: The importance of pre-transplantation metabolic screening in recurrent urolithiasis. , 2015, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[10]  S. Yıldırım,et al.  Liver and kidney transplant in primary hyperoxaluria: a single center experience. , 2015, Experimental and Clinical Transplantation.

[11]  J. Lieske,et al.  Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria. , 2015, Journal of the American Society of Nephrology : JASN.

[12]  M. Daudon,et al.  Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria , 2015, Canadian journal of kidney health and disease.

[13]  D. Samuel,et al.  Long‐term results of combined liver‐kidney transplantation for primary hyperoxaluria type 1: The French Experience , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  E. Salido,et al.  The lower limits for protein stability and foldability in primary hyperoxaluria type I. , 2014, Biochimica et biophysica acta.

[15]  R. Belostotsky,et al.  Mutations in HAO1 encoding glycolate oxidase cause isolated glycolic aciduria , 2014, Journal of Medical Genetics.

[16]  E. Salido,et al.  Protein Homeostasis Defects of Alanine-Glyoxylate Aminotransferase: New Therapeutic Strategies in Primary Hyperoxaluria Type I , 2013, BioMed research international.

[17]  G. Rumsby.  Primary Hyperoxaluria Type 2 , 2011 .

[18]  E. Salido,et al.  Phenotypic correction of a mouse model for primary hyperoxaluria with adeno-associated virus gene transfer. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  M. Houshmand,et al.  Recurrence of primary hyperoxaluria after kidney transplantation. , 2011, Iranian journal of kidney diseases.

[20]  M. Pakarinen,et al.  Long-Term Renal Function in Children After Liver Transplantation , 2011, Transplantation.

[21]  E. Bergstralh,et al.  Transplantation Outcomes in Primary Hyperoxaluria , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[22]  C. Akkın,et al.  Regressive course of oxalate deposition in primary hyperoxaluria after kidney transplantation , 2010, Renal failure.

[23]  V. Tasic,et al.  Late diagnosis of primary hyperoxaluria after failed kidney transplantation , 2010, International Urology and Nephrology.

[24]  P. Murlidharan,et al.  Recurrence of primary hyperoxaluria: an avoidable catastrophe following kidney transplant. , 2008, Journal of postgraduate medicine.

[25]  E. Salido,et al.  Alanine–glyoxylate aminotransferase-deficient mice, a model for primary hyperoxaluria that responds to adenoviral gene transfer , 2006, Proceedings of the National Academy of Sciences.

[26]  Hyeon-Hoe Kim,et al.  Late-onset primary hyperoxaluria diagnosed after renal transplantation presented with early recurrence of disease. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[27]  Riksen Np,et al.  Renal graft failure due to type 1 primary hyperoxaluria. , 2002 .

[28]  P. Desmond,et al.  Primary hyperoxaluria type I. , 1994, Australasian radiology.

[29]  E. Salido,et al.  Generation and characterization of human iPSC lines derived from a Primary Hyperoxaluria Type I patient with p.I244T mutation. , 2016, Stem cell research.

[30]  P. Cochat,et al.  Primary hyperoxaluria. , 2013, The New England journal of medicine.

[31]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[32]  J. Lieske,et al.  Primary Hyperoxaluria Type 1 , 1993 .